Focus on CLL and NHL: What are the implications of the data from EHA 2021 on clinical practice?
Agenda
Learning objective:
After participating in this webinar, viewers should be able to:
- Discuss the data presented during EHA 2021 relating to the treatment of CLL and selected B-cell lymphomas and its potential impact on daily clinical practice
Agenda:
13.00 Introduction – Angeline Zhu
13.05-13.30 CLL in the spotlight - Paolo Ghia
13.30-13.50 Discussion
13.50-14.10 Focus on B-cell lymphomas (MCL and WM) – Steven Le Gouill
14.10-14.20 Discussion
14.20-14.30 Q+A
Moderators:
- Angeline Zhu (Janssen)
Faculty:
- Paolo Ghia (Italy)
- Steven Le Gouill (France)